These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9549577)

  • 1. Malignant giant-cell tumours of bone. Clinico-pathological types and prognosis: a review of 29 cases.
    Anract P; De Pinieux G; Cottias P; Pouillart P; Forest M; Tomeno B
    Int Orthop; 1998; 22(1):19-26. PubMed ID: 9549577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary malignant giant-cell tumor of bone has high survival rate.
    Domovitov SV; Healey JH
    Ann Surg Oncol; 2010 Mar; 17(3):694-701. PubMed ID: 19902306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant treatment with zoledronic acid after extensive curettage for giant cell tumours of bone.
    Gouin F; Rochwerger AR; Di Marco A; Rosset P; Bonnevialle P; Fiorenza F; Anract P
    Eur J Cancer; 2014 Sep; 50(14):2425-31. PubMed ID: 25088085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective analysis of 51 intralesionally treated cases with progressed giant cell tumor of the bone: local adjuvant use of hydrogen peroxide reduces the risk for tumor recurrence.
    Omlor GW; Lange J; Streit M; Gantz S; Merle C; Germann T; Mechtersheimer G; Fellenberg J; Lehner B
    World J Surg Oncol; 2019 Apr; 17(1):73. PubMed ID: 31014317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Giant cell tumor of the cervical spine: a series of 22 cases and outcomes.
    Junming M; Cheng Y; Dong C; Jianru X; Xinghai Y; Quan H; Wei Z; Mesong Y; Dapeng F; Wen Y; Bin N; Lianshun J; Huimin L
    Spine (Phila Pa 1976); 2008 Feb; 33(3):280-8. PubMed ID: 18303460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for recurrence of giant cell tumours of bone.
    Siddiqui MA; Seng C; Tan MH
    J Orthop Surg (Hong Kong); 2014 Apr; 22(1):108-10. PubMed ID: 24781627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors of local recurrence of giant cell tumor of long bone after treatment: plain radiographs, pathology and surgical procedures.
    Chanchairujira K; Jiranantanakorn T; Phimolsarnti R; Asavamongkolkul A; Waikakul S
    J Med Assoc Thai; 2011 Oct; 94(10):1230-7. PubMed ID: 22145509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence of curetted and bone-grafted giant-cell tumours with and without adjuvant phenol therapy.
    Trieb K; Bitzan P; Lang S; Dominkus M; Kotz R
    Eur J Surg Oncol; 2001 Mar; 27(2):200-2. PubMed ID: 11289759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Factors related to biologic behavior in giant cell tumor of bone].
    Ran XY; Huang J; Zhang HZ; Jiang ZM; Chen J
    Zhonghua Bing Li Xue Za Zhi; 2013 Oct; 42(10):669-74. PubMed ID: 24433729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multicentric giant cell tumor: clinical analysis of 9 cases].
    Li X; Guo W; Yang RL; Yang Y
    Zhonghua Yi Xue Za Zhi; 2013 Dec; 93(45):3602-5. PubMed ID: 24534311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term administration of bisphosphonate to reduce local recurrence of sacral giant cell tumor after nerve-sparing surgery.
    Xu W; Wang Y; Wang J; Yang X; Liu W; Zhou W; Liu T; Xiao J
    J Neurosurg Spine; 2017 Jun; 26(6):716-721. PubMed ID: 28338455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of benign giant cell tumours of bone in Singapore.
    Lim YW; Tan MH
    Ann Acad Med Singap; 2005 Apr; 34(3):235-7. PubMed ID: 15902343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical observation of surgical management for recurrent giant cell tumor of bone].
    Kong Q; Yang J; Xing R; Tu C; Zhou Y; Zhang H; Duan H
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jan; 27(1):36-40. PubMed ID: 23427489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical treatment of giant cell tumour of long bone with anhydrous alcohol adjuvant.
    Oh JH; Yoon PW; Lee SH; Cho HS; Kim WS; Kim HS
    Int Orthop; 2006 Dec; 30(6):490-4. PubMed ID: 16736146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence of a primary malignant giant cell tumour of bone 14 years after initial surgery.
    Merad M; Mesurolle B; Guinebretière JM; Lecesne A; Missenard G; Vanel D
    Eur Radiol; 2001; 11(8):1483-6. PubMed ID: 11519561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Giant cell tumor of bone: risk factors for recurrence.
    Klenke FM; Wenger DE; Inwards CY; Rose PS; Sim FH
    Clin Orthop Relat Res; 2011 Feb; 469(2):591-9. PubMed ID: 20706812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.
    Wojcik J; Rosenberg AE; Bredella MA; Choy E; Hornicek FJ; Nielsen GP; Deshpande V
    Am J Surg Pathol; 2016 Jan; 40(1):72-80. PubMed ID: 26414220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual bone fragments in tibiofibular joint and postoperative local recurrence: an analysis of 21 cases of proximal fibular giant cell tumour.
    Liu Y; Moro A; Wang K; Huang X; Wei C; Chen K; Xiao Z; Zhan X; Tang H
    World J Surg Oncol; 2018 Nov; 16(1):228. PubMed ID: 30482206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective cohort study of 68 sacral giant cell tumours treated with nerve-sparing surgery and evaluation on therapeutic benefits of denosumab therapy.
    Lim CY; Liu X; He F; Liang H; Yang Y; Ji T; Yang R; Guo W
    Bone Joint J; 2020 Feb; 102-B(2):177-185. PubMed ID: 32009426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Giant cell tumours of bone. A DNA-flow cytometric study.
    Heliö H; Karaharju E; Böhling T; Nordling S
    Eur J Surg Oncol; 1994 Jun; 20(3):200-6. PubMed ID: 8181593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.